Fundraising FoxAarvik Therapeutics
Hayward, US · Founded 2020 · Delaware corporation · 1 known investors
Find your way into Aarvik Therapeutics
Sign up to see every warm intro you have to Aarvik Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Aarvik Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Aarvik Therapeutics was founded in 2020 by Jagath Reddy Junutula.
JR
Jagath Reddy JunutulaFounderJagath Reddy Junutula is an executive at Aarvik Therapeutics with over 25 years in life sciences research as a biochemist and molecular cell biologist, including 20 years focused on oncology drug discovery; he developed the THIOMAB technology platform for engineering antibody-drug conjugates and has advanced multiple antibody-based therapeutics from discovery through IND stages.
Board
AJ
SS
Sachdev SidhuBoard director
RK
Ram Kalakoti ReddyBoard director
RS
Richard SchellerBoard director
Investors · 1
Funding
SEC filings, press & company announcements$9.5M disclosed across 2 of 3 rounds · 2021–2025
- Undisclosed amountSeries Seed 2Sep 2025Source ↗
▶$1.2MraisedDec 2024 · 5 investors · PharmaceuticalsRule 506(b)
▶$1.2MraisedDec 2024 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Sachdev SidhuDirector
- Anula JayasuriyaDirector
- Jagath Reddy JunutulaExecutive Officer, Director
- Ram Kalakoti ReddyDirector
- Richard SchellerDirector
- Offering amount
- $15M
- Amount sold
- $1.2M
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$8.3MraisedSep 2021 · 112 investors · PharmaceuticalsRule 506(b)
▶$8.3MraisedSep 2021 · 112 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Jagath Reddy JunutulaExecutive Officer, Director
- Anula JayasuriyaDirector
- Richard SchellerDirector
- Offering amount
- $8.3M
- Amount sold
- $8.3M
- Proceeds to insiders
- $500K
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Aarvik Therapeutics?
- Aarvik Therapeutics was founded by Jagath Reddy Junutula in 2020.
- Who are Aarvik Therapeutics's investors?
- Aarvik Therapeutics's investors include DigitalDx Ventures.
- How much funding has Aarvik Therapeutics raised?
- Aarvik Therapeutics has disclosed $9.5M raised across 2 of its 3 known rounds.
- Where is Aarvik Therapeutics headquartered?
- Aarvik Therapeutics is headquartered in Hayward, US.